INTRODUCTION
Although Bordetella bronchiseptica is said to be commonly encountered as both a commensal and a cause of respiratory tract disease in many wild and domestic animals, it has rarely been implicated as a cause of infection in humans. The purpose of this paper is to present a critical review of the literature in which human infections with B. bronchiseptica have been reported. First, the bacteriologic and pathologic characteristics of the microorganism are described. Second, its role as a commensal and as a human pathogen is examined. Data from two patients from whom we isolated B. bronchiseptica are included in the review.
BACTERIOLOGY OF B. BRONCHISEPTICA Bacteriological Characteristics of Bordetellae
The genus Bordetella comprises three species, B. pertussis, B. parapertussis, and B. bronchiseptica. The microbiological characteristics that distinguish the three species are summarized in Table 1 . A fourth species, Bordetella avium, has been proposed by Kersters et al. (93) . This putative species, a cause of turkey coryza, closely resembles Alcaligenes faecalis and is not yet distinctly differentiated from it (113) .
Bordetella pertussis, the major cause of whooping cough, was characterized by Bordet and Gengou (18) in 1906 . Bradford and Slavin (19) in 1937 and Eldering and Kendrick (52) in 1938 distinguished B. parapertussis from B. pertussis because the former grew more rapidly on primary isolation, was oxidase negative, and produced pigment on tyrosine agar. They incriminated B. parapertussis as a minor cause of whooping cough, particularly a milder form than that caused by B. pertussis. Both species are extremely fastidious, requiring direct inoculation of nasopharyngeal swab material onto special media such as or ReganLowe (137) whooping cough patients (102) and the apparent conversion of B. pertussis to B. parapertussis by loss of a lysogenic bacteriophage (77) casts doubt on the validity of designating B. parapertussis as a separate species.
Ferry (61) (62) (63) , using the name Bacillus bronchisepticus; McGowan (111) , using the term Bacillus bronchicanis; and Torrey and Rahe (161) , using Ferry's epithet, independently observed the association of a small gram-negative coccobacillus with outbreaks of "canine distemper" and respiratory tract illness in laboratory animals such as the cat, rabbit, and guinea pig. Because it was known later by a variety of names such as Haemophilus bronchiseptica (134) , Brucella bronchiseptica (134) , Bacillus suisepticus (44) , Alcaligenes bronchicanis (134) , and Alcaligenes bronchisepticus (134) , the microorganism's taxonomic status and etiologic role in disease were hampered by both the state of the evolving microbiology and its commensal or opportunistic field of involvement in then poorly understood viral infections such as distemper (2, 48, 99, 159, 169) . In 1952, Lopez (104) proposed that the bacterium be placed in the genus Bordetella, and thus it was assigned as B. bronchiseptica in the seventh edition of Bergey's Manual of Systematic Bacteriology (20) . However, until the studies of Johnson and Sneath in 1973 (89) and Bemis et al. (11) in 1977, the microorganism was not well distinguished from certain phenotypically similar isolates, particularly some members of the genera Acinetobacter, Achromobacter, Alcaligenes, Pseudomonas, and Brucella. The morphological and biochemical characteristics of B. bronchiseptica are now considered to be as follows. It is an obligate aerobe, grows readily on simple nutritive media as small circular glistening or rough colonies 0.5 to 1.0 mm in diameter after 48 h of incubation in air at 35°C, is gram negative, and exhibits small bacillary morphology with peritrichous flagella. It is positive in tests for catalase, oxidase, citrate utilization, motility, urease, nitrate reduction, tetrazolium reduction, and growth on salmonellashigella agar, and it is negative in tests for indole, acid production in oxidation-fermentation glucose and maltose media, tyrosine hydrolysis, and growth on tellurite agar. Although most isolates reduce nitrate and are motile, exceptions occur (11, 133, 166) . Motility is best demonstrated in semisolid agar at 30°C. B. bronchiseptica can be conve- Table  2 . Although some discrepancies exist among the studies, probably as the result of methodologic differences, the response to a number of agents appears to be predictable and similar to that expected for nonfermentative gram-negative bacilli, particularly Pseudomonas aeruginosa. The aminoglycosides (amikacin, gentamicin, and tobramycin) appear to be highly effective in vitro against B. bronchiseptica, whereas streptomycin (11, 60) appears to be generally ineffective. The antipseudomonal penicillins azlocillin, mezlocillin, piperacillin, and ticarcillin also show a near 100% effectiveness in vitro, whereas the primary penicillins, ampicillin and penicillin G, appear to be considerably less effective although MICs, especially of ampicillin, could be considered as representing low-level resistance. Near 100% effectiveness is also exhibited in vitro for the antipseudomonal broad-spectrum cephalosporins, cefoperazone and ceftazidime, whereas other broad-spectrum cephalosporins show a broad variability of effectiveness. (122, 123) . Discrepancies in susceptibility test results for the studies summarized in Table 2 (8-10, 12, 73, 158, 160) some five decades after the initial independent observations of Ferry (61) (62) (63) (64) (65) , McGowan (111) , and Torrey and Rahe (161) . On the basis of recent studies using the most stringent conditions (11, 89) (12) . The infection is accompanied by mild infiltration of neutrophils and lymphocytes in the submucosa and by moderate hyperplasia of adjacent lymphoid tissues (12, 159) . These findings are similar to those described in early studies comparing the pathological changes in canine bordetellosis with those observed in autopsy studies of patients who died with complications of whooping cough (107) (108) (109) 138) . Mallory et al. (107) (108) (109) proposed that the bacteria cause mechanical blocking of the respiratory cilia, resulting in failure of the respiratory tract to clear mucus secretions.
Bacterial adherence and ciliostasis has since been demonstrated by others as well (14, 36, 45-47, 110, 162, 165) . Corroborating evidence for the differential tropism and adherence of Bordetella species to respiratory epithelial cells has also come from in vitro studies (88, 97, 119, 162) . Tuomanen and associates (162) (11, 13, 71, 88, 92 animal erythrocytes and is distinctly independent from lipopolysaccharide endotoxin (87) . This toxin produces turbinate atrophy accompanied by bone loss and chronic inflammation when applied intranasally or injected parenterally into young swine. The Bordetella species are also known to secrete adenylate cyclase (31, 57, 86) , a substance that interferes with bactericidal, secretory, and other physiological processes of epithelial cells. Unless complicated by superinfection or a secondary event such as laryngospasm, the pathological changes associated with human and canine bordetellosis appear to be self-limiting and completely resolve with time.
By the late 1960s, it seemed to be clearly established that B. bronchiseptica was the agent responsible for a syndrome in swine characterized by turbinate atrophy, snout deformity, pneumonia, and failure to thrive (5, 34, 44, 46, 49, 101, 141) . Of special influence were the studies by Switzer and associates (47, 82, (141) (142) (143) in which the disease was produced by repeated inoculation of aerosolized cultures of B. bronchiseptica into the nares of young disease-free pigs. In both field and experimental studies, the pathological changes observed were those of a progressive atrophy of the turbinates with squamous and goblet cell metaplasia of the mucosa, a mild to moderate acute inflammatory reaction within the submucosa, and damage to the developing turbinate bones characterized by increased osteoclastic activity and fibrous metaplasia of osteoblasts. Damage to the turbinates was shown to be due to the action of a dermonecrotic toxin because turbinate atrophy was produced by either intranasal or parenteral injection of the toxin into young swine. The mechanism was thought to be related to disruption of the energy-coupled formation and deposition of calcium apatite in newly forming bone (24, 80, 82, 84, 85, 140) . Observations against the acceptance of B. bronchiseptica as the cause of atrophic rhinitis were (i) the variable effectiveness of vaccine preparations (15, 16, 59, 70, 72, 74, 83, 129) , (ii) the transient nature of the experimental disease unless maintained by repeated inoculation of the organism (1, 69, 103, 125, 130, 163) , (iii) the ready isolation of the agent from healthy swine and as a common commensal or opportunist in animals with viral and other respiratory diseases (17, 69, 75, 76, 130, 143, 145, 147) , and (iv) the detection of other potential pathogens such as Pasteurella multocida by more discriminative microbiological methods (69, 81, 125, 130, 149 121, 148, 150) .
In a situation analogous to the developments in swine atrophic rhinitis, B. bronchiseptica was thought to be the probable cause of snuffles, otitis media, and tracheal bronchitis in rabbits and guinea pigs (64, 78, 106, 151, 152, 167, 168) . Evidence now indicates that P. multocida is the major pathogen, with B. bronchiseptica possibly playing an inducing or opportunistic role (36, 39, 40, 117 Cases with Verified B. bronchiseptica Identification As the result of a motorcycle accident, a 26-year-old male (case 1) suffered a C-4 vertebral fracture with trauma to the cervical spinal cord, producing an acute quadriplegia with some preservation of upper extremity motor function. On return to the surgical intensive care unit after an emergency decompression of the spinal cord, he was noted to be gagging and was thought to have aspirated gastric contents. Aspiration was confirmed by an emergency bronchoscopy, the tracheobronchial tree was cleared, and cultures of the material later grew a variety of both aerobic and anaerobic microorganisms. Following bronchoscopy the patient was intubated, placed on a respirator, and started on clindamycin and gentamicin therapy. On the following day a right lower lobe atelectasis and infiltrate were noted, temperature was elevated to 101 to 103°F (38.3 to 39.4°C) and a neutrophilic leukocytosis developed over the next few days, peaking at 21.4 x 103 leukocytes (WBC)/mm3 on the ninth postoperative day with a return to normal by day 16. Sputum specimens obtained by endotracheal aspirations on days 4 and 6 grew only oropharyngeal flora. An endotracheal sputum specimen obtained on day 9 grew >90% B. bronchiseptica. The microorganism was initially identified by the Vitek AMS and API 20E systems and was later confirmed by standard microbiological methods, using current stringent criteria (11, 89) . Susceptibility testing by the Vitek AMS System showed the microorganism to be susceptible to amikacin, carbenicillin, ciprofloxacin, mezlocillin, piperacillin, and tobramycin and resistant to cefotaxime and ceftazidime. Because of persisting right lower lobe atelectasis and difficulty in clearing secretions, a therapeutic bronchoscopy was performed on day 10 showing approximately 90% combined neutrophils and band forms. Blood gases and electrolytes were within normal limits except for a sodium of 134 meq/liter, potassium of 3.4 meq/liter, and glucose of 282 mg/dl. The patient was placed on intravenous cefotaxime and clindamycin, was given dilantin and valproate, and, as a known diabetic, was maintained on NPH insulin. Four blood specimens drawn before the administration of antibiotics, and four subsequent blood specimens, were sterile. Urine specimens obtained on admission and 2 days later were sterile. Sputum cultures on admission and 2 days later showed a scanty growth of normal respiratory flora. On the fourth hospital day the patient was taken to the operating room for direct laryngoscopy. The tonsillar and peritonsillar areas were erythematous and swollen, and a defect in the lower pole of the left tonsil leading into the left lateral pharyngeal wall suggested the possibility of a previously expressed abscess. Pus was not obtainable by punctures of the hypopharyngeal area. The epiglottis was erythematous and swollen, with tissues at the base of the epiglottis and left false chord appearing necrotic and friable. A left tonsillectomy was performed and biopsies and cultures were taken from the base of the epiglottis, the lateral hypopharyngeal wall, and the tonsillar defect. Microscopic examination of the tonsil material showed partially ulcerated mucosa with acute and chronic inflammatory cells in the stroma. Sections of the other biopsies showed necrotic tissue with acute inflammation. Only one small portion of tissue showed respiratory tract epithelium, and bacteria associated with the ciliated epithelium were not demonstrated by careful search of Gram-and toluidine blue-stained VOL. 4 Cultures of the sinus material for anaerobes, mycobacteria, and fungi were negative. By the Automicrobic System, the B. bronchiseptica isolate was susceptible to carbenicillin, gentamicin, tetracycline, tobramycin, and trimethoprim-sulfamethoxazole and was resistant to ampicillin, cefamandole, cefoxitin, cephalothin, and chloramphenicol. During the remainder of the hospitalization the patient continued to be febrile, and neurologic function was not restored. The patient died 4 weeks after admission and an autopsy was not performed. Aside from having a pet dog, there were no known animal contacts. In summary, although B. bronchiseptica appeared to play a pathogenic role in the acute maxillary sinusitis, its role in the acute laryngopharyngitis remains speculative. This case illustrates the difficulty in assigning pathogenic or commensal roles for B. bronchiseptica in the cases reviewed. In the case described by Papasian and colleagues (128) the patient was a 60-year-old male (case 4) who presented with acute bronchitis and pneumonia. He was known to have had chronic lymphocytic leukemia for 6 years and was treated by splenectomy 3 years previously and recently by chemotherapy. Initial bilateral bronchial washings and catheter brush specimens, as well as sputum cultures obtained during a recrudescence 5 days later, grew large numbers of B. bronchiseptica, which was identified by API 20E and subsequently confirmed by the Missouri Department of Health. The initial episode of tracheobronchitis was apparently resolved by amikacin and cefazolin treatment; however, sputum cultures remained positive. The recrudescence was successfully treated with oral trimethoprim-sulfamethoxazole. The case appears to be that of a valid respiratory tract B. bronchiseptica infection in a compromised host.
Katzenstein and colleagues (91) described a 70-year-old male (case 5) with hepatic failure, gastrointestinal bleeding, and sickle cell traits, who developed septicemia on the 18th hospital day. B. bronchiseptica was recovered from multiple premortem blood cultures obtained on separate days and from postmortem liver and spleen cultures. The organism was identified by using the API 20E system and was confirmed by the Centers for Disease Control. At autopsy, except for the nonspecific signs of sepsis, an infectious focus was not found. The case appears to be that of a valid B. bronchiseptica sepsis in a compromised host.
Stoll and coworkers (154) described a 26-year-old female (case 7) with long-standing Hodgkins disease, who presented with pneumonia and pleural infection following chest tube placement for a developing pneumothorax. The patient's dog had died 5 days previously after developing rhinorrhea and a cough. Staphylococcus aureus was isolated from one blood culture, and S. aureus and B. bronchiseptica were recovered from a sputum culture. The isolate was identified by using standard methods and appropriately stringent microbiological criteria (11, 89) . Both the S. aureus and the B. bronchiseptica isolates were found to be susceptible to cefazolin. The recovery of S. aureus from both blood and sputum suggests that S. aureus was the major pathogen. The recovery of B. bronchiseptica from the sputum only suggests a superinfection or commensal role in a compromised host.
Ghosh and Tranter (68) described a 73-year-old male debilitated alcoholic (case 8) with bilateral pneumonia and right lung abscess from whom bronchoscopic and tracheal aspiration cultures grew mixed aerobic and anaerobic bacteria, including B. bronchocanis; the latter also was recovered from one blood culture. The isolate was identified by using standard methods and appropriately stringent microbiological criteria (11, 89) . This case appears to be that of a valid B. bronchiseptica pneumonia and sepsis in a compromised host.
Snell (153) alluded to the use of a reference microorganism that he had identified as B. bronchiseptica. The microorganism was sent to him by Khaled (94) , who had recovered it in a blood culture from a patient (case 10) with a typhoidlike syndrome. The microbiological characteristics and criteria for identification of the microorganism as B. bronchiseptica were not presented. Through the courtesy of J. J. S. Snell (Central Public Health Laboratory, London, England), we obtained a lyophilized sample of the original culture from the National Collection of Type Cultures. In our laboratory the isolate was identified as B. bronchiseptica by the API 20E and Vitek AMS systems and by standard microbiological methods (11, 89) . The case appears to be that of a valid B. bronchiseptica septicemia in a host who was possibly compromised.
Kristensen and Lautrop (96) described a farm family in which the three younger children (cases 14 to 16) developed whooping cough symptoms shortly after the onset of a respiratory tract illness in some of their farm animals which resulted in the death of four of six rabbits and three of five cats. B. bronchiseptica was said to have been isolated from the nasopharyngeal secretions of a 5-year-old boy with whooping cough symptoms for 6 weeks, a 7-year-old boy with whooping cough symptoms for 5 weeks, an older boy with a cough for 3 days, three asymptomatic older siblings, and from two of the surviving cats. The microorganism was not recovered from the mother, father, or the three older siblings. B. pertussis and B. parapertussis were said to have been carefully looked for on Bordet-Gengou primary plates and were not found. Microbiological characteristics for identification included appropriate Gram stain and flagellar morphology; positive reactions for oxidase, motility, nitrate reduction, and urease; and no acid production from glucose. Lyophilized samples of the original cultures from four of the siblings were kindly supplied to us by Wilhelm Frederiksen, Statens Seruminstitut, Copenhagen, Denmark; in our laboratory each was identified as B. bronchiseptica by the API 20E, API NFT, and Vitek AMS systems and by standard microbiological methods (11, 89) . These cases appear to represent valid recoveries of B. bronchiseptica from humans; however, the causal role in disease is unclear. Although the syndrome resembled whooping cough, appropriate microbiological methods failed to detect B. pertussis and B. parapertussis. It is possible that the upper respiratory tract illnesses in the family were of viral etiology and that the recovery of B. bronchiseptica represented the incidental Cases with Unverified B. bronchiseptica Identification In the remaining 15 reports summarized below, the microbiological findings either were not presented or did not meet the currently accepted standards for B. bronchiseptica identification, the latter problem roughly paralleling the age of the report.
Buggy and colleagues (25) described a 55-year-old swine farmer (case 3) with chronic lymphocytic leukemia for 4 years who presented with an acute pneumonia responding to tetracycline. A relapse of the pneumonia 4 months later responded to erythromycin. B. bronchiseptica was isolated from two respiratory tract cultures during each episode. Unfortunately, no details were given as to the microbiological methods and criteria used for identification. Attempts by us to obtain subcultures of the original isolates from these cases were unsuccessful. The response of the second pneumonic episode to erythromycin weighs against B. bronchiseptica as a cause.
Byrd and coworkers (26) described a 60-year-old male dialysis patient (case 6) with signs of peritonitis, from whom a single peritoneal dialysis fluid culture yielded a gramnegative coccobacillus identified as B. bronchiseptica on the basis of positive catalase, oxidase, motility, nitrate reduction, and urease tests. The patient had had close contact with a pet dog during dialysis manipulations. Because of his failure to improve on intraperitoneal and intravenous gentamicin and cephalothin administered for 48 h, therapy was changed to intraperitoneal and intravenous chloramphenicol. Complete resolution of fever, abdominal pain, and turbidity of the dialysate resulted after 5 days. Susceptibility studies showed resistance to ampicillin, cephalothin, gentamicin, amikacin, and tobramycin and susceptibility to tetracycline, trimethoprim-sulfamethoxazole, and chloramphenicol. This uniform resistance to the aminoglycosides would be highly unusual for B. bronchiseptica.
Chang and colleagues (27) recovered B. bronchiseptica from two separate specimens of cerebrospinal fluid obtained from a 19-year-old boy (case 9) who developed signs and symptoms of meningitis following repair of an orbital fracture due to a horse kick. The patient completely recovered after treatment with chloramphenicol and methicillin administered intravenously for 9 days followed by intravenous ampicillin for 2 weeks. Cultures of the patient's cat, dog, and gerbils did not yield B. bronchiseptica. The microbiological methods and criteria for identification were not presented.
In a prospective study of 190 cases of whooping cough confirmed by either the fluorescent antibody test or culture, or both, Brooksaler and Nelson (21) found only one instance in which B. bronchiseptica was thought to have been isolated. This was an 8-year-old boy (case 13) who also had a sick rabbit. Characteristics for identification were not described, were not included in the cited references, and were not available on inquiry.
Dale and Geraci (35) briefly mentioned a 60-year-old male (case 17) with long-standing endocarditis from whom a C02-dependent S. aureus was recovered in 6 of 11 blood cultures; 3 of the positive cultures also grew a microorganism designated as B. bronchiseptica. Other than describing the microorganism as a small gram-negative motile bacillus requiring room temperature and increased CO2 for isolation, other features were not described.
Winsser (169) Chang (28) described a 2-year-old boy (case 21) with whooping cough symptoms for 1 month from whom a microorganism, thought initially to be B. pertussis, was repeatedly isolated from nasopharyngeal cultures. The microorganism was not recovered from several nasal cultures of the patient's pet dog. The primary culture after 48 h on Bordet-Gengou medium showed numerous, pinhead-sized colonies that were smooth and glistening, with narrow zones of P-hemolysis, and were composed of gram-negative coccobacilli that were agglutinated with B. pertussis antiserum to a titer of 640. The microorganism was found to be positive for oxidase, motility, and nitrate reduction and negative for indole, gas and acid production from dextrose, lactose, maltose, and saccharose and was agglutinated by B. bronchiseptica antiserum to a titer of 10 to grow pure cultures of the same microorganism. The isolates from the child and the rabbit were compared with a strain of B. bronchiseptica obtained from the stock collection of the Society of American Bacteriologists and were found to be alike in every respect. The isolates produced hemolysis on heavy inoculation, an ammoniacal odor, and an alkaline reaction in dextrose broth and were motile. Agglutination studies with sera of rabbits injected with isolates from the child, rabbit, and stock strain showed a common agglutination pattern for all strains and did not agglutinate a B. pertussis strain. In this case, the use of blood agar in the initial attempt at isolating a pathogen by cough plate inoculation probably accounts for the failure to recover either B. pertussis or B. parapertussis. In addition, at that time the latter organism was not recognized as a pathogen.
In an early report (65) and in a personal communication to Brown (22), Ferry described isolating B. bronchiseptica in pure culture from the sputum of a symptomatic adult male laboratory worker (case 24) who had been exposed to guinea pigs with B. bronchiseptica infection. The microbiological characteristics of the isolate were presumably those described by Ferry in an earlier report of B. bronchiseptica infection in dogs (62) . Colonies grew slowly to pinpoint size on plain agar after 48 h with gram-negative organisms having coccobacillary morphology. The isolates were motile, produced slow alkalinization of litmus milk, and were negative for gelatin liquefaction, indole, and production of acid and gas from a number of carbohydrates. These characteristics fall short of today's requirements for identification of B. bronchiseptica.
McGowan (111) alluded to an adult male animal caretaker (case 25) from whom a culture of mucopus from the palate yielded B. bronchiseptica. The microbiological characteristics, as with Ferry's report, were minimal.
CONCLUSIONS
The aim of this comprehensive literature search for cases of human infection associated with B. bronchiseptica was to assess the propensity for disease involvement and virulence of the microorganism for humans. The taxonomic status of the microorganism, the pathological findings and probable pathogenic mechanisms associated with the agent, and the potential of B. bronchiseptica to act as a human commensal were examined. It is apparent that stringent criteria corresponding to those recommended by Bemis et al. (11) and Johnson and Sneath (89) for differentiating B. bronchiseptica from phenotypically similar oxidase-positive nonfermentative gram-negative coccobacilli were not used before the 1970s. Because of this, most case reports before that time lack a description of one or more of the characteristics needed to verify the microorganism as B. bronchiseptica. In several instances, the agent may have been B. bronchiseptica because four of the initially unverified cases were subsequently verified when we confirmed the organisms' identity.
Except for inferences that can be drawn by reviewing the pathology and pathogenic mechanisms described for B. bronchiseptica infections in animals and from autopsy studies of humans who died from complications of whooping cough, specific information on the pathology of human B. bronchiseptica infection is lacking. Studies before the 1970s of B. bronchiseptica as a human commensal or colonizer lack the use of appropriately stringent microbiological characteristics. Also, except in surveys of gram-negative nonfermentative bacilli isolated in microbiology laboratories, it might be expected that isolations of B. bronchiseptica from healthy people would not be reported. From the information available, it appears that B. bronchiseptica may be isolated occasionally as a commensal or colonizer, particularly from respiratory sources. The incidence of isolation is highly dependent on the intensity of and methods used to search for the microorganism.
For this review, 25 cases of human infection thought to be associated with B. bronchiseptica were available for analysis, 2 from our experience and 23 from the literature. Each case was evaluated for the accuracy of the B. bronchiseptica identification and for the likelihood that the microorganism played a causal role. Of the 23 cases obtained from the literature review, the accuracy of B. bronchiseptica identification could be verified for only 8 cases. The infections encountered for the 10 verified cases (our 2 cases plus 8 from the literature review) were acute iatrogenic maxillary sinusitis (one), nosocomial tracheobronchitis (one), acute pneumonia (two), pneumonia with septicemia (one), septicemia (two), and whooping cough (three). For the whooping cough cases, it is likely that B. bronchiseptica acted as a colonizer and not as the cause. Of the seven remaining verified cases, six were definitely in compromised patients (three debilitated alcoholics, one with chronic lymphocytic leukemia, one with long-standing Hodgkin's disease, and one diabetic with severe epiglottitis and hypoxic brain death), and for one inadequate clinical information was presented to assess whether the patient was compromised. Only one of the seven patients was known to have had contact with a sick animal. In all of the cases, the outcome of antimicrobial treatment was difficult to assess. In case 1 the patient died as the result of severe hypoxic brain damage, while in cases 5 and 8 the patients died as a consequence of their severe hepatic disease. In case 4 the initial episode of acute bronchitis with pneumonia responded to combined amikacin and cefazolin therapy and a recrudescence shortly thereafter responded to trimethoprim-sulfamethoxazole. In case 7 the pneumonia and infected pneumothorax were treated successfully with cefazolin, a situation suggesting that the S. aureus recovered from both sputum and pleural drainage was the primary pathogen rather than the B. bronchiseptica recovered only from sputum. Case 2 represented a patient with a cervical spine fracture and postoperative aspiration pneumonia in which B. bronchiseptica later appeared to cause opportunistic superinfection. From recent in vitro antimicrobial susceptibility studies of B. bronchiseptica, the most effective agents appear to be the aminoglycosides, the antipseudomonal penicillins and broad-spectrum cephalosporins, the tetracyclines, and chloramphenicol.
The 15 cases from the literature for which the identity of B. bronchiseptica could not be verified comprised four patients with pneumonia, three representing compromised hosts and one with close animal contact; three children with whooping cough, each having had contact with sick animals; three animal caretakers with chronic laryngotracheitis; acute peritonitis in a patient on peritoneal dialysis having had close contact with a pet dog; meningitis in a child kicked in the head by a horse; and three inadequately described cases of two patients with endocarditis and one with acute sinusitis. For the three cases of whooping cough there were valid reasons for excluding B. bronchiseptica as the causative agent. In each of the remaining cases, the microbiological findings, although inadequate, did not weigh against identification of the agent as B. bronchiseptica. Thus, it is possible that B. bronchiseptica was actually involved. As with the verified cases, a compromised host was involved in many VOL. 4, 1991 on October 27, 2017 by guest http://cmr.asm.org/ Downloaded from 252 WOOLFREY AND MOODY instances, particularly when the agent seemed to be of etiological importance.
From this review, we conclude that B. bronchiseptica has rarely been isolated from humans despite the considerable exposure of humans to animal sources of the microorganism. Evidence suggests that the agent may occasionally be encountered as a commensal or colonizer of the human respiratory tract and, rarely, as a pathogen in human disease. When encountered as a probable pathogen, most patients have a severely compromised clinical status. Carefully planned future studies using appropriate microbiological procedures and stringent characteristics for identification of B. bronchiseptica are needed to determine the true incidence of the agent as a human commensal or colonizer and to evaluate further its role as an opportunistic and/or primary cause of disease.
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